ID: MRFR/HC/6356-HCR | 85 Pages | Author: Kinjoll Dey | March 2024
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1. Porterβs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis
Chapter 6. Global Orthobiologics Market, by Product
6.1. Introduction
6.2. Demineralized bone matrix (DBM)
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.3. Bone morphogenetic protein (BPM)
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.4. Allograft
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.5. Viscosupplementation products
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.6. Synthetic bone substitutes
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
6.7. Others
Chapter 7. Global Orthobiologics Market, by Application
7.1. Introduction
7.2. Osteoarthritis & degenerative arthritis
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.3. Spinal fusion
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.4. Fracture recovery
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.5. Soft tissue injuries
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
7.6. Others
Chapter 8. Global Orthobiologics Market, by End User
8.1. Introduction
8.2. Hospitals
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.3. Orthopedic Clinics
Market Estimates & Forecast, by Region, 2020β2027
Market Estimates & Forecast, by Country, 2020β2027
8.4. Others
Chapter 9. Global Orthobiologics Market, by Region
9.1. Introduction
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
Chapter 10. Company Landscape
10.1. Introduction
10.2. Market Share Analysis
10.3. Key Developments & Strategies
Chapter 11. Company Profiles
11.1. Arthrex, Inc.
11.1.1. Company Overview
11.1.2. Product Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Exactech, Inc.
11.2.1. Company Overview
11.2.2. Product Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Globus Medical Inc
11.3.1. Company Overview
11.3.2. Product Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Integra LifeSciences
11.4.1. Company Overview
11.4.2. Product Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Johnson & Johnson
11.5.1. Company Overview
11.5.2. Product Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Medline Industries, Inc
11.6.1. Company Overview
11.6.2. Product Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. NuVasive, Inc.
11.7.1. Company Overview
11.7.2. Product Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Stryker Corporation
11.8.1. Company Overview
11.8.2. Product Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Wright Medical Group N.V.
11.9.1. Company Overview
11.9.2. Product Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Zimmer Biomet
11.10.1. Company Overview
11.10.2. Product Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Others
Chapter 12. MRFR Conclusion
12.1. Key Findings
12.1.1. From CEOβs Viewpoint
12.1.2. Unmet Needs of the Market
12.2. Key Companies to Watch
12.3. Predictions for the Orthobiologics Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1. Global Orthobiologics Market Synopsis, 2020β2027
Table 2. Global Orthobiologics Market Estimates and Forecast, 2020β2027 (USD Million)
Table 3. Global Orthobiologics Market, by Region, 2020β2027 (USD Million)
Table 4. Global Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 5. Global Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 6. Global Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 7. North America: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 8. North America: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 9. North America: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 10. US: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 11. US: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 12. US: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 13. Canada: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 14. Canada: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 15. Canada: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 16. Latin America: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 17. Latin America: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 18. Latin America: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 19. Europe: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 20. Europe: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 21. Europe: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 22. Western Europe: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 23. Western Europe: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 24. Western Europe: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 25. Eastern Europe: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 26. Eastern Europe: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 27. Eastern Europe: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 28. Asia-Pacific: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 29. Asia-Pacific: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 30. Asia-Pacific: Orthobiologics Market, by End User, 2020β2027 (USD Million)
Table 31. Middle East & Africa: Orthobiologics Market, by Product, 2020β2027 (USD Million)
Table 32. Middle East & Africa: Orthobiologics Market, by Application, 2020β2027 (USD Million)
Table 33. Middle East & Africa: Orthobiologics Market, by End User, 2020β2027 (USD Million)
LIST OF FIGURES
Figure 1. Research Process
Figure 2. Segmentation for Global Orthobiologics Market
Figure 3. Segmentation Market Dynamics for Global Orthobiologics Market
Figure 4. Global Orthobiologics Market Share, by Product, 2020
Figure 5. Global Orthobiologics Market Share, by Application, 2020
Figure 6. Global Orthobiologics Market Share, by End User, 2020
Figure 7. Global Orthobiologics Market Share, by Region, 2020
Figure 8. North America: Orthobiologics Market Share, by Country, 2020
Figure 9. Europe: Orthobiologics Market Share, by Country, 2020
Figure 10. Asia-Pacific: Orthobiologics Market Share, by Country, 2020
Figure 11. Middle East & Africa: Orthobiologics Market Share, by Country, 2020
Figure 12. Global Orthobiologics Market: Company Share Analysis, 2020 (%)
Figure 13. Arthrex, Inc.: Key Financials
Figure 14. Arthrex, Inc.: Segmental Revenue
Figure 15. Arthrex, Inc.: Geographical Revenue
Figure 16. Exactech, Inc.: Key Financials
Figure 17. Exactech, Inc.: Segmental Revenue
Figure 18. Exactech, Inc.: Geographical Revenue
Figure 19. Globus Medical Inc: Key Financials
Figure 20. Globus Medical Inc: Segmental Revenue
Figure 21. Globus Medical Inc: Geographical Revenue
Figure 22. Integra LifeSciences: Key Financials
Figure 23. Integra LifeSciences: Segmental Revenue
Figure 24. Integra LifeSciences: Geographical Revenue
Figure 25. Johnson & Johnson: Key Financials
Figure 26. Johnson & Johnson: Segmental Revenue
Figure 27. Johnson & Johnson: Geographical Revenue
Figure 28. Medline Industries, Inc: Key Financials
Figure 29. Medline Industries, Inc: Segmental Revenue
Figure 30. Medline Industries, Inc: Geographical Revenue
Figure 31. NuVasive, Inc.: Key Financials
Figure 32. NuVasive, Inc.: Segmental Revenue
Figure 33. NuVasive, Inc.: Geographical Revenue
Figure 34. Stryker Corporation: Key Financials
Figure 35. Stryker Corporation: Segmental Revenue
Figure 36. Stryker Corporation: Geographical Revenue
Figure 37. Wright Medical Group N.V.: Key Financials
Figure 38. Wright Medical Group N.V.: Segmental Revenue
Figure 39. Wright Medical Group N.V.: Geographical Revenue
Figure 40. Wright Medical Group N.V.: Key Financials
Figure 41. Wright Medical Group N.V.: Segmental Revenue
Figure 42. Wright Medical Group N.V.: Geographical Revenue
Orthobiologics Market Segmentation
Orthobiologics Product Outlook (USD Billion, 2018-2030)
Demineralized Bone Matrix
Bone Morphogenetic Protein
Orthobiologics Application Outlook (USD Billion, 2018-2030)
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Orthobiologics End User Outlook (USD Billion, 2018-2030)
Hospitals
Orthopedic Clinics
Orthobiologics Regional Outlook (USD Billion, 2018-2030)
North America Outlook (USD Billion, 2018-2030)
North America Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
North America Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
North America Orthobiologics by End User
Hospitals
Orthopedic Clinics
US Outlook (USD Billion, 2018-2030)
US Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
US Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
US Orthobiologics by End User
Hospitals
Orthopedic Clinics
CANADA Outlook (USD Billion, 2018-2030)
CANADA Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
CANADA Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
CANADA Orthobiologics by End User
Hospitals
Orthopedic Clinics
Europe Outlook (USD Billion, 2018-2030)
Europe Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Europe Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Europe Orthobiologics by End User
Hospitals
Orthopedic Clinics
Germany Outlook (USD Billion, 2018-2030)
Germany Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Germany Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Germany Orthobiologics by End User
Hospitals
Orthopedic Clinics
France Outlook (USD Billion, 2018-2030)
France Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
France Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
France Orthobiologics by End User
Hospitals
Orthopedic Clinics
UK Outlook (USD Billion, 2018-2030)
UK Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
UK Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
UK Orthobiologics by End User
Hospitals
Orthopedic Clinics
ITALY Outlook (USD Billion, 2018-2030)
ITALY Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
ITALY Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
ITALY Orthobiologics by End User
Hospitals
Orthopedic Clinics
SPAIN Outlook (USD Billion, 2018-2030)
Spain Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Spain Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Spain Orthobiologics by End User
Hospitals
Orthopedic Clinics
Rest Of Europe Outlook (USD Billion, 2018-2030)
Rest Of Europe Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
REST OF EUROPE Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
REST OF EUROPE Orthobiologics by End User
Hospitals
Orthopedic Clinics
Asia-Pacific Outlook (USD Billion, 2018-2030)
Asia-Pacific Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Asia-Pacific Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Asia-Pacific Orthobiologics by End User
Hospitals
Orthopedic Clinics
China Outlook (USD Billion, 2018-2030)
China Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
China Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
China Orthobiologics by End User
Hospitals
Orthopedic Clinics
Japan Outlook (USD Billion, 2018-2030)
Japan Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Japan Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Japan Orthobiologics by End User
Hospitals
Orthopedic Clinics
India Outlook (USD Billion, 2018-2030)
India Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
India Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
India Orthobiologics by End User
Hospitals
Orthopedic Clinics
Australia Outlook (USD Billion, 2018-2030)
Australia Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Australia Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Australia Orthobiologics by End User
Hospitals
Orthopedic Clinics
Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
Rest of Asia-Pacific Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Rest of Asia-Pacific Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Rest of Asia-Pacific Orthobiologics by End User
Hospitals
Orthopedic Clinics
Rest of the World Outlook (USD Billion, 2018-2030)
Rest of the World Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Rest of the World Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Rest of the World Orthobiologics by End User
Hospitals
Orthopedic Clinics
Middle East Outlook (USD Billion, 2018-2030)
Middle East Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Middle East Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Middle East Orthobiologics by End User
Hospitals
Orthopedic Clinics
Africa Outlook (USD Billion, 2018-2030)
Africa Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Africa Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Africa Orthobiologics by End User
Hospitals
Orthopedic Clinics
Latin America Outlook (USD Billion, 2018-2030)
Latin America Orthobiologics by Product
Demineralized Bone Matrix
Bone Morphogenetic Protein
Latin America Orthobiologics by Application
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Latin America Orthobiologics by End User
Hospitals
Orthopedic Clinics